FDA Grants Anixa Biosciences' Individual Patient IND for Second Dose of CAR-T Ovarian Cancer Therapy
Jul 23, 2024
Therapy Invest Information
Innovative COPD Therapy Dupixent Gains Approval in the EU, Marking a First for Targeted Treatment
Jul 4, 2024
FDA Grants Accelerated Approval to Ipsen and Genfit's Iqirvo for Liver Disease Treatment
Jun 12, 2024
GENFIT Reaches Historic FDA Approval with Ipsen's Iqirvo® for Primary Biliary Cholangitis
Jun 11, 2024
Eisai Submits LEQEMBI® (lecanemab-irmb) Biologics License Update to FDA for Early Alzheimer's Treatment – Biogen Stocks in Focus
Jun 10, 2024
BioNTech Projects Ten Oncology Trials by End of 2024 Leading to First Launch in 2026
Mar 20, 2024
MindMed's Strategic Shift in 2024: Focusing on Anxiety Treatments and Halting LSD Microdosing for ADHD
Jan 11, 2024
StockNews.com Initiates Coverage on Lipocine (LPCN), Impacts of Institutional Trading Highlighted
Nov 12, 2023
PharmAla Begins Groundbreaking Observational Trial for Real-World Efficacy of MDMA Therapy
Nov 9, 2023
Pioneering Observational Trial on MDMA Treatment Kicks Off with PharmAla, Heroic Hearts, and University of Calgary
Nov 9, 2023
PharmAla, University of Calgary, and Heroic Hearts Canada Launch Observational MDMA Efficacy Trial
Nov 9, 2023